ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1860

Fibromyalgia and the Disease and Statistical Manual Classification As a Somatic Symptom Disorder

Frederick Wolfe1, Brian T. Walitt2 and Winfried Häuser3, 1National Data Bank for Rheumatic Diseases, Wichita, KS, 2Rheumatology, Washington Hospital Center, Washington, DC, 3Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, Munich, Germany

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: fibromyalgia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Fibromyalgia and Soft Tissue Disorders

Session Type: Abstract Submissions (ACR)

Background/Purpose: Fibromyalgia was first defined by rheumatologists, and is often thought of as a disorder of widespread pain and decreased pain threshold. In the wider literature, however, including non-US studies, fibromyalgia is considered to be one of a series of “medically unexplained syndromes.” These illnesses are sometimes called somatic symptom disorders (SSD) or functional somatic syndromes because the main symptoms, pain, fatigue, cognitive disturbance, and unrefreshed sleep, are somatic and have no clear etiological explanation. This definition, however, comes into conflict with the Diagnostic and Statistical Manual-5 (DSM) of SSD mental illnesses draft criteria of April-27-2012. DSM-5 defines a SSD as a mental illness when all of A and B are present chronically: A) one or more somatic symptoms that are distressing and/or result in significant disruption in daily life; B) persistently high level of anxiety about health or symptoms OR excessive time and energy devoted to these symptoms or health concerns.

Methods : We studied 13,229 rheumatic disease patients, including 3,657 who satisfied ACR 2010 criteria for fibromyalgia modified for survey research and 9,572 who did not meet criteria. We calculated the criteria Symptom Severity score (SS4) and omitted the non-somatic depression symptom of SS4. We defined patients as probably DSM-5 positive if they had at least one of the following symptoms, fatigue, cognitive disturbance, unrefreshed sleep present which was defined at a severity level of “Severe: continuous, life-disturbing problems.”  DSM-5 status was defined as definite if they had at least 2 of the 3 symptoms at a severe level or had an average SS4 of at least 10 of a possible 12.

Results : See Table 1. 35.0% of FM positive patients were positive at a definite level, 2.6% of non-FM criteria patients were positive. Probable DSM positivity in FM patients was indicated by 39.3% with severe fatigue scores, 42.2% with severe unrefreshed sleep, and 15.8% with severe cognitive problems.

Conclusion : Using severity measures from survey modified ACR 2010 fibromyalgia criteria, we noted high rates of DSM-5 SSD positivity. At least 35% of FM patients would be classified as having an SSD mental disorder using our definitions. These results are inconsistent with clinical experience and call into question the use of proposed DSM criteria in clinical populations. Moreover, many, including us, would argue that all FM patients have an SSD, though not necessarily a mental disorder. Our results should be regard with caution because our definitions used ad hoc measures based on FM assessments, and it is possible that different levels of abnormalities might have been found using the Whitely Index mentioned in DSM-5. However, such an index is not used outside of psychiatric clinics and does not appear germane to FM symptoms. The DSM-5 continues to be revised.

Percent satisfying DSM-5 criteria

Category

Percent Positive

Possible DSM (+)

   Severe fatigue

39.3

   Severe unrefreshed sleep

42.2

   Severe cognitive problems

15.8

Definite DSM (+)

   At least 2 of 3 positive

33.6

   At least 2 of 3 positive or SS4 score >=10

35.0


Disclosure:

F. Wolfe,
None;

B. T. Walitt,
None;

W. Häuser,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fibromyalgia-and-the-disease-and-statistical-manual-classification-as-a-somatic-symptom-disorder/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology